Back to URGN
D. E. Shaw & Co., Inc. URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
9
Latest value
$42.2M
Q2 2026
Peak value
$42.2M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $471K |
| Q4 2023 | $1.2M |
| Q2 2024 | $182K |
| Q2 2025 | $376K |
| Q3 2025 | $17.7M |
| Q4 2025 | $22.3M |
| Q4 2025 | $291K |
| Q1 2026 | $18.4M |
| Q2 2026 | $42.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $42.2M | 1.15M | — | — |
| Q1 2026 | $18.4M | 1.02M | — | — |
| Q4 2025 | $291K | 12.4K | — | — |
| Q4 2025 | $22.3M | 950.2K | — | — |
| Q3 2025 | $17.7M | 888.9K | — | — |
| Q2 2025 | $376K | 27.4K | — | — |
| Q2 2024 | $182K | 10.8K | — | — |
| Q4 2023 | $1.2M | 77.9K | — | — |
| Q3 2023 | $471K | 33.6K | — | — |
Other funds holding URGN
$93.6M
$57M
$57M
$48M
$48M
$45M